Hello Bio News
Hello Bio launches small molecules for genome editing
Hello Bio announced today the launch of a range of small molecules that can be used for genome editing – including 4-Hydroxytamoxifen, azidothymidine and RS-1. These...
Hello Bio launches water soluble Clozapine N-oxide – a DREADD ligand
Hello Bio announced today the launch of a water soluble DREADD ligand, Clozapine N-oxide (CNO) – an exciting tool for scientists studying GPCR signaling.
GPCRs can be...
Hello Bio Scientific Advisory Board member wins The Brain Prize – the ‘Nobel Prize for neuroscientists’
Professor Graham Collingridge, a member of Hello Bio’s Scientific Advisory Board has won The Brain Prize together with Professor Tim Bliss of University College London, and...
Hello Bio opens new US office in New Jersey
Hello Bio announced today the opening of its new USA office, based in New Jersey.
Researchers in the USA, Canada and South America will benefit from faster delivery times and an...
Low cost Tetrodotoxin (TTX) launched by Hello Bio - to help neuroscientists
Hello Bio announced today the launch of low cost tetrodotoxin (TTX) – a sodium channel blocker used by scientists carrying out electrophysiology techniques to investigate...
Hello Bio sponsors Pharmacology 2015 conference at QEIICC in London
Hello Bio is Silver Sponsor of Pharmacology 2015, the annual conference of the British Pharmacology Society (BPS).
Pharmacology 2015 is being held at the QEII conference centre...
Hello Bio develops state-of-the-art chemical laboratory
Hello Bio has commenced work on a state-of-the-art chemical laboratory complex to further develop its range of affordable high quality life science research tools and to enhance...
Hello Bio exhibits at 40th FEBS Congress in Berlin
Hello Bio, the affordable life science company is supporting European biochemists and molecular biologists by exhibiting at the ‘Biochemical Basis of Life’ 40th FEBS...
Novel, selective GRK2/3 inhibitor Cmpd101 launched by Hello Bio
Today Hello Bio announced the launch of a novel, potent and selective G-protein coupled receptor kinase 2 and 3 (GRK2/3) inhibitor, Cmpd101.
GRKs are key regulators of GPCR...
Hello Bio supports Bristol University's 10th anniversary celebrations
Hello Bio Sponsors Bristol University's Dorothy Hodgkin Building 10th Anniversary Symposium
Nobel prize winner Prof John O’Keefe from UCL and Prof David Nutt of...
Novel mGlu8-selective antagonist MDCPG launched by Hello Bio
Hello Bio announced today the launch of a novel mGlu8 selective antagonist MDCPG – to help scientists investigate epilepsy, anxiety and Alzheimer’s Disease.
mGlu8...
Hello Bio launches new website - supporting researchers worldwide
Stand-out life science company launches hellobio.com, offering affordable research tools together with financial support for researchers
Hello Bio has launched a new website...
Hello Bio Sponsors Pharmacology 2014 Conference at QEIICC in London
Hello Bio, the affordable life science company, is sponsoring the British Pharmacology Society (BPS) Pharmacology 2014 conference held at the QEII conference centre in London on...
Hello Bio supports autism research at mGlu glutamate conference
Hello Bio, the affordable life science company, is supporting glutamate researchers at the 8th International Conference on Metabotropic Glutamate Receptors in Taormina,...
Hello Bio: launch of exciting new life science company benefits researchers worldwide
New life science company offers affordable research tools together with financial support for researchers
Hello Bio was launched today to support scientific researchers...